Pharming Group NV (PHARM) — Cash Flow Reinvestment Rate
Pharming Group NV (PHARM) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting €93.00K (capex €70.00K plus investments €23.00K) from operating cash flow of €32.03 Million. See PHARM free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharming Group NV Cash Flow Reinvestment Rate (2017–2022)
Historical reinvestment intensity for Pharming Group NV across 6 annual periods. For the full cash flow conversion analysis, see Pharming Group NV operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Pharming Group NV (2017–2022)
Year-by-year capital reinvestment analysis for Pharming Group NV. See Pharming Group NV leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.41x | €9.28 Million | €22.90 Million | €1.98 Million | ▼ -28.8% |
| 2021 | 0.57x | €20.55 Million | €36.13 Million | €15.96 Million | ▲ +208.0% |
| 2020 | 0.18x | €16.80 Million | €90.98 Million | €16.47 Million | ▼ -51.3% |
| 2019 | 0.38x | €28.25 Million | €74.56 Million | €25.44 Million | ▲ +145.9% |
| 2018 | 0.15x | €7.12 Million | €46.19 Million | €4.31 Million | ▼ -27.6% |
| 2017 | 0.21x | €9.76 Million | €45.84 Million | €7.25 Million | — |